Celulitis: una guía para la práctica

1. Hersh AL. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008;168(14):1585.

2. Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 2006;20(7):834–9.

3. Peterson RA, Polgreen LA, Cavanaugh JE, et al. Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis 2017;4(1): ofx008.

4. Bernard P. Streptococcal cause of erysipelas and cellulitis in adults. Arch Dermatol 1989;125(6):779.

5. Jeng A, Beheshti M, Li J, et al. The role of b-hemolytic streptococci in causing diffuse, nonculturable cellulitis. Medicine 2010;89(4):217–26.

6. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59(2):e10–52.

7. Miller LG, Remington FP, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible s. aureus infection: a prospective investigation. Clin Infect Dis 2007;44(4):471–82.

8. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-Resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352(14):1436–44.

9. Spindel SJ, Strausbaugh LJ, Jacobson C. Infections caused by Staphylococcus aureus in a Veterans’ Affairs nursing home care unit a 5-year experience. Infect Control Hosp Epidemiol 1995;16(4):217–23.

10. Mathews WC, Caperna JC, Barber RE, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;40(2):155–60.

11. Jackson KA, Bohm MK, Brooks JT, et al. Invasive methicillinresistantstaphylococcus aureusinfections among persons who inject drugs —six sites, 2005–2016. MMWR Morb Mortal Wkly Rep 2018;67(22):625–8.

12. Schneider-Lindner V, Delaney JA, Dial S, et al. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus,United Kingdom. Emerging Infect Dis 2007;13(7):994–1000.

13. Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillinresistant staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 2004;39(10):1446–53.

14. Aiello AE, Lowy FD, Wright LN, et al. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis 2006;6(6):335–41.

15. Abrahamian FM, Goldstein EJC. Microbiology of animal bite wound infections. Clin Microbiol Rev 2011;24(2):231–46.

16. Griego RD, Rosen T, Orengo IF, et al. Dog, cat, and human bites: a review. J Am Acad Dermatol 1995;33(6):1019–29.

17. Finkelstein R, Oren I. Soft tissue infections caused by marine bacterial pathogens. Epidemiol Diagn Management 2011;13(5):470–7. Cellulitis 733

18. Shimizu S, Shimizu H. Cutaneous manifestations ofHelicobacter cinaedi: a review. Br J Dermatol 2016;175(1):62–8.

19. Jorge P, Parada JNM. Clinical syndromes associated with adult pneumococcal cellulitis. Scand J Infect Dis 2000;32(2):133–6.

20. McNamara DR, Tleyjeh IM, Berbari EF, et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county, Minnesota. Mayo Clin Proc 2007;82(7):817–21.

21. Quirke M, Ayoub F, McCabe A, et al. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol 2017;177(2):382–94.

22. Raff AB, Kroshinsky D. Cellulitis. JAMA 2016;316(3):325. 23. Lopez M, Roberson ML, Strassle PD, et al. Epidemiology of Lymphedema-related admissions in the United States: 2012–2017. Surg Oncol 2020;35:249–53.

24. Tay EY, Fook-Chong S, Oh CC, et al. Cellulitis Recurrence Score: a tool for predicting recurrence of lower limb cellulitis. J Am Acad Dermatol 2015;72(1):140–5.

25. Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect 2012;64(2):148–55.

26. Koutkia P, Mylonakis E, Boyce J. Cellulitis: evaluation of possible predisposing factors in hospitalized patients. Diagn Microbiol Infect Dis 1999;34(4):325–7.

27. Kulthanan K, Rongrungruang Y, Siriporn A, et al. Clinical and microbiologic findings in cellulitis in Thai patients. J Med Assoc Thai 1999;82(6):587–92.

28. Lazzarini L, Conti E, Tositti G, et al. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 2005;51(5):383–9.

29. Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics. J Am Acad Dermatol 2012;67(2):163.e1–12.

30. Raff AB, Weng QY, Cohen JM, et al. A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional study. J Am Acad Dermatol 2017;76(4): 618–25.e2.